February 25, 2020
Company name: Mitsubishi Tanabe Pharma Corporation
Representative:

Masayuki Mitsuka
President & Representative Director

Code number:

4508, First Section, Tokyo Stock Exchange

Contact:

Yoshiaki Takai, Vice President,
Head of Corporate Communications Dept.
(TEL: +81-6-6205-5211)

Change in Representative Director
Osaka (February 25, 2020) – The Board of Directors of Mitsubishi Tanabe Pharma
Corporation has today approved the following proposal to appoint a new Representative
Director.
1. Change in Representative Director (effective April 1, 2020)
New Role
Member of the Board

NameTakashi Kobayashi

Current Role
Representative Director,
Senior Managing Executive Officer,
in charge of Digital Transformation
Department

Representative Director,

Eizo Tabaru

Member of the Board,

Managing Executive Officer,

Managing Executive Officer,

in charge of Corporate

in charge of Corporate Strategy &Management Department,

Planning Department, NeuroDerm

Corporate Communications

Office, Finance & Accounting

Department, Legal & General

Department, Corporate

Affairs Department, Japan

Communications Department

Quality Assurance Office
2. Reason for the Change
The Company has decided to change its representative director in order to build Mitsubishi
Tanabe Pharma groupʼs global governance system, strengthen its management control
functions, and promote global growth, a management issue.
Under the new leadership structure, the Company will strive to strengthen its management
and enhance its corporate value toward further progress.

13. Biography of the New Representative Director
Name:

Eizo Tabaru

Date of birth:

July 3, 1958 (61 years old)

Education:

Keio University, Faculty of Business and Commerce, Graduate

Number of company shares owned:

9,500

Professional Career:
April 1981

Entered Mitsubishi Chemical Industries Ltd.

April 2010

General Manager of Finance and Accounting Department of Mitsubishi
Chemical Corporation

June 2010

Associate Director, General Manager of Finance and Accounting
Department of Mitsubishi Chemical Corporation

April 2012

Executive Officer, General Manager of Finance and Accounting
Department of Mitsubishi Chemical Corporation

April 2014

Executive Officer, General Manager of Finance & Accounting
Department of the Company

June 2015

Member of the Board, Executive Officer, General Manager of Finance& Accounting Department of the Company

April 2016

Member of the Board, Managing Executive Officer, General Managerof Finance & Accounting Department of the Company

April 2017

Member of the Board, Managing Executive Officer, in charge ofCorporate Strategy & Planning Department, Finance & Accounting
Department, Corporate Communications Department and ICTManagement Department of the Company

April 2018

Member of the Board, Managing Executive Officer, in charge ofCorporate Strategy & Planning Department, NeuroDerm Office,Finance & Accounting Department and Corporate Communications
Department of the Company (current)

April 2020

To be appointed Representative Director, Managing Executive Officer,
in charge of Corporate Management Department, Corporate
Communications Department, Legal & General Affairs Department
and Japan Quality Assurance Department of the Company

4. Planned Date of Change
April 1, 2020
-End-2